Pear Therapeutics, Inc.: eps_diluted
| Value | {"per": "shares", "amount": -0.76, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-09-30 |
| Status | current |
| Entity | Pear Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fbd699a7-bf33-45c8-b780-1a165b835ada
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001835567-22-000076 · Open the official SEC filing →Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001835567/eps-diluted/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fbd699a7-bf33-45c8-b780-1a165b835ada
History
- no predecessors — first report